SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-047776
Filing Date
2023-04-20
Accepted
2023-04-20 16:18:31
Documents
8
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231948-1_def14a.htm DEF 14A 817624
2 GRAPHIC bc_peovsnetincome-4clr.jpg GRAPHIC 163512
3 GRAPHIC bc_peovstsr-4clr.jpg GRAPHIC 184167
4 GRAPHIC lg_caratmtherap-4c.jpg GRAPHIC 42885
5 GRAPHIC px_proxypg1caratherape-bw.jpg GRAPHIC 698774
6 GRAPHIC px_proxypg2caratherape-bw.jpg GRAPHIC 493614
7 GRAPHIC sg_christopherposner-bwlr.jpg GRAPHIC 18818
8 GRAPHIC sg_scottterrillion-bwlr.jpg GRAPHIC 12325
  Complete submission text file 0001104659-23-047776.txt   2740734
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 23833342
SIC: 2834 Pharmaceutical Preparations